Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis

Abstract

Visceral leishmaniasis is a vector-borne protozoan infection that is fatal if untreated. There is no vaccination against the disease, and the current chemotherapeutic agents are ineffective due to increased resistance and severe side effects. Buparvaquone is a potential drug against the leishmaniases, but it is highly hydrophobic resulting in poor bioavailability and low therapeutic efficacy. Herein, we loaded the drug into silicon nanoparticles produced from barley husk, which is an agricultural residue and widely available. The buparvaquone-loaded nanoparticles were several times more selective to kill the intracellular parasites being non-toxic to macrophages compared to the pure buparvaquone and other conventionally used anti-leishmanial agents. Furthermore, the in vivo results revealed that the intraperitoneally injected buparvaquone-loaded nanoparticles suppressed the parasite burden close to 100%. By contrast, pure buparvaquone suppressed the burden only by 50% with corresponding doses. As the conclusion, the biogenic silicon nanoparticles are promising carriers to significantly improve the therapeutic efficacy and selectivity of buparvaquone against resistant visceral leishmaniasis opening a new avenue for low-cost treatment against this neglected tropical disease threatening especially the poor people in developing nations.

Carbon Dots Embedded in Nanoporous SiO2 Nanoparticles for Enhancing Photosynthesis in Agricultural Crops

“…These results demonstrate that the synthesis of NanoSi was successful and the optimal NanoSi was produced by the 1:1 reaction system of formaldehyde and resorcinol with TEOS at 550 °C. NanoSi surfaces with a rough hairy material, as well as the existence of empty structures and surface voids, could serve as excellent nanocarriers for target materials, thereby improving its bioavailability. , For example, the parasite inhibition rate of bubatroxone loaded onto NanoSi was close to 100% . Therefore, this spherical hairy material might be an excellent nanocarrier for many materials.…”

Innovating Leishmaniasis Treatment: A Critical Chemist’s Review of Inorganic Nanomaterials

“…Thapa and co-workers produced mesoporous silica (MSNPs) from barley ash, an agricultural industry residue, and observed a significant in vivo reduction of L. donovani parasite burden by incorporating buparvaquone (BPQ) into the MSNPs. 198 Buparvaquone, a drug with poor water solubility, benefits from improved bioviability when delivered through MSNPs, potentially reducing the toxicity associated with BPQ. The authors found that the BPQ-loaded MSNPs exhibited good biocompatibility, increasing the CC 50 by ca.…”

Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates

“…Buparvaquone is a promising leishmaniasis medication, although it has low bioavailability and therapeutic efficacy due to its hydrophobic nature. The parasite burden was nearly completely decreased by intraperitoneally administered buparvaquone-loaded (biogenic silicon nanoparticles) silicon nanoparticles made from barley husk, an agricultural residue that is commonly available [150].…”